Saluda Medical, Inc. (ASX:SLD)

Market Cap	148.69M
Revenue (ttm)	114.04M +242.1%
Net Income	-378.77M
EPS	-9.84
Shares Out	252.02M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	383,410
Average Volume	218,430
Open	0.6020
Previous Close	0.6250
Day's Range	0.5850 - 0.6150
52-Week Range	0.5850 - 2.6500
Beta	n/a
RSI	25.03
Earnings Date	May 27, 2026

About Saluda Medical

Saluda Medical, Inc., a medical device company, develops Evoke, an investigational device for the neuromodulation industry in the United States, Australia, the United Kingdom, and the Netherlands. The company develops a closed-loop spinal cord stimulation system that measures the spinal cord's response to stimulation and adjusts on every pulse to optimize activation within the patient's therapeutic window. It also offers an application to sense, measure, and adjust the pulse. The company was founded in 2011 and is based in Bloomington, Minnesot...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2011
• Employees: 133
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: SLD

Financial Performance

In fiscal year 2025, Saluda Medical's revenue was $70.36 million, an increase of 36.13% compared to the previous year's $51.68 million. Losses were -$149.30 million, 52.6% more than in 2024.

Financial numbers in USD